Florida Best Practice Medication Adult Guidelines
Adobe Acrobat Reader is required to view the guidelines below

Florida Best Practice Medication Guidelines for Optimal Monitoring of Patients

• All clinicians should strive to use routine objective measures for appropriate symptom monitoring, health monitoring, and monitoring for EPS, expecially Tardive Dyskinesia that are consistent with existing professional practice
• Organizations should develop policies and procedures for optimal monitoring of patients with Bipolar Disorder and Schizophrenia
  

1. Antipsychotic Polypharmacy: State of Science and Guidelines for Practice (updated 11/2009)
   
   
2. Florida Best Practice Medication Guidelines for the Treatment of Bipolar I Disorder Adult Acute Depression (updated 7/2009)
   
   
3. Florida Best Practice Medications Guidelines for the Treatment of Bipolar I Disorder Adult Acute Mania (updated 7/2009)
   
   
4. Review of the Recent literature on Bipolar Disorder (updated 11/2009)
   
   
5. Florida Best Practice Medication Guidelines for Bipolar Maintenance Therapy (updated 7/2009)
   
   
6. Florida Best Practice Medication Guidelines for Treatment of Adult Major Depressive Disorder - Nonpsychotic
   
   
7. Florida Best Practice Medication Guidelines for Treatment of Adult Major Depressive Disorder - Psychotic
   
   
8. Florida Best Practice Medication Guidelines Principles of Practice for Antipsychotics Use in Adults (updated 7/2009)
   
   
9. Florida Best Practice Medication Guidelines for Schizophrenia (updated 7/2009)
   
   
10. Summary Review of Recent Antipsychotic Treatment of Patients with Schizophrenia (updated 11/2009)
    
    
11. Recommended Dosage Range for the Treatment of Bipolar I Disorder(updated 7/2009)
    

Disclaimer: The Florida Best Practices Medication Guidelines for the use of psychotropic medication in psychotropic medication in adults reflect the state of knowledge, current at the time of publication, on effective and appropriate care, as well as clinical consensus judgments when research is lacking. The inevitable changes in the state of scientific information and technology mandate that periodic review, updating, and revisions will be needed. These guidelines do not apply to all patients and each must be adapted and tailored to each individual patient. Proper use, adaptation, modifications, or decisions to disregard these or other guidelines, in whole or in part, are entirely the responsibility of the clinician who uses the guidelines. The authors bear no responsibility for the use of these guidelines by third parties.

Level Framework for Best Practice Guidelines
The panel decided to use the existing format of the Adult Florida Best Practice Guidelines, where instead of creating an algorithm where specific options were mandatory or had to be used first or diagrammatically looked like the had to be used first, the child expert panel decided to categorize options in different levels, based upon strength of science and expert consensus regarding a particular agent or treatment option. The panel weighed both safety and efficacy issues when assigning particular treatment options to a Level. Level 1 options were considered to have stronger evidence and consensus than level 2 and below. The panel chose this approach with an understanding that using a particular option in any level would depend upon clinical judgment and patient or family needs or preferences. Level 0 refers to an assessment level prior to any decisions regarding treatment options.